BENCIVENGA, Maria
 Distribuzione geografica
Continente #
NA - Nord America 1.815
EU - Europa 1.807
AS - Asia 1.076
AF - Africa 48
SA - Sud America 10
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.768
Nazione #
US - Stati Uniti d'America 1.806
CN - Cina 595
GB - Regno Unito 443
SG - Singapore 307
IT - Italia 245
RU - Federazione Russa 244
IE - Irlanda 213
SE - Svezia 211
FR - Francia 163
DE - Germania 96
FI - Finlandia 79
VN - Vietnam 53
UA - Ucraina 35
JP - Giappone 33
KR - Corea 27
TG - Togo 24
RW - Ruanda 21
AT - Austria 18
BE - Belgio 15
ID - Indonesia 15
HK - Hong Kong 14
NL - Olanda 14
CA - Canada 9
AU - Australia 8
TW - Taiwan 6
ES - Italia 5
IL - Israele 5
BR - Brasile 4
KG - Kirghizistan 4
PT - Portogallo 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
EU - Europa 3
LK - Sri Lanka 3
NO - Norvegia 3
PE - Perù 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
EG - Egitto 2
GR - Grecia 2
IN - India 2
LU - Lussemburgo 2
LV - Lettonia 2
PL - Polonia 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
SN - Senegal 1
TH - Thailandia 1
Totale 4.768
Città #
Southend 413
Chandler 407
Singapore 249
Dublin 209
Jacksonville 156
Ashburn 126
Beijing 121
Verona 101
Ann Arbor 92
Redmond 78
New York 77
Woodbridge 73
Lawrence 62
Princeton 62
Houston 60
Jinan 55
Wilmington 48
Helsinki 45
Nanjing 42
Shenyang 37
Tokyo 30
Hebei 27
Seoul 27
Sindelfingen 27
Los Angeles 25
Dong Ket 24
Lomé 24
Kigali 21
Changsha 18
Tianjin 18
Guangzhou 17
Haikou 17
Falls Church 16
Brussels 15
Nanchang 15
Hong Kong 14
Jakarta 14
Milan 14
Ningbo 14
Taizhou 14
Dallas 13
Moscow 13
Seattle 13
Vienna 12
Washington 12
Zhengzhou 12
Amsterdam 11
Jiaxing 11
Hangzhou 10
Lappeenranta 10
Fuzhou 9
Boardman 8
Redwood City 8
Santa Clara 8
Auburn Hills 6
Erba 6
Lancaster 6
Norwalk 6
Renton 6
San Francisco 6
Tombolo 6
Paris 5
Bishkek 4
Bologna 4
Cagliari 4
Klagenfurt 4
Sant'Ambrogio di Valpolicella 4
Tel Aviv 4
Adelaide 3
Baku 3
Castiglione Olona 3
Colombo 3
Detroit 3
Dongguan 3
Frankfurt am Main 3
Kent 3
Lanzhou 3
Lima 3
London 3
Melbourne 3
Mira 3
Oslo 3
Ottawa 3
Rome 3
San Diego 3
Toronto 3
Trento 3
Ancona 2
Athens 2
Bassano del Grappa 2
Berlin 2
Boydton 2
Brno 2
Cairo 2
Caneva 2
Cesena 2
Chicago 2
Chions 2
Clearwater 2
Columbus 2
Totale 3.208
Nome #
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 140
Shape and volume of internal anal sphincter showed by three-dimensional anorectal ultrasonography 135
Proton Magnetic Resonance Spectroscopy: Ex vivo study to investigate its prognostic role in colorectal cancer. 130
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 129
Genomic characterization of hepatoid tumors: context matters 110
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 107
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 100
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 95
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 95
Lymphadenectomy for gastric cancer at European specialist centres 91
Short-term and long-term risk factors in gastric cancer 90
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 90
Western strategy for EGJ carcinoma 90
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 90
One stage or two stage treatment of colorectal cancer associated to abdominal aortic aneurysm: morbidity and mortality. 87
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 85
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 83
Lymphadenectomy: how to do it? 82
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 77
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 76
Management of critically ill surgical patients Case reports 76
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 75
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 74
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 74
Complications after gastrectomy for cancer: Italian perspective 73
Do all the European surgeons perform the same D2? The need of D2 audit in Europe 73
Clinical pathways in gastric cancer care 72
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 71
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 71
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 69
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 68
Methylation Dynamics of RASSF1A and Its Impact on Cancer 66
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 66
Tailored treatment for signet ring cell gastric cancer 63
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 63
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 61
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 61
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 58
Surgical treatment of hepatic metastases from gastric cancer 58
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 58
An aggressive early gastric cancer: Kodama's PenA type 56
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 54
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 53
Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer 52
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 52
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 51
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 50
A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194 50
Personalized therapeutic strategies in HER2-driven gastric cancer 50
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 49
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer 48
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits 47
Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study 47
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 46
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition 45
Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group's analysis 44
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial 43
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 42
Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy 42
Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study 40
Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer 37
The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples 37
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas 31
On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer 30
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 29
Beyond years: evaluating the impact of surgeon age on outcomes after gastric cancer surgery 28
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer 28
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe 28
Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis 28
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment 28
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 25
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 24
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 24
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape 22
Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial 21
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe 20
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 20
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 19
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 17
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 16
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) 15
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab 15
Prophylactic Total Gastrectomy: Techniques 15
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series 14
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice 14
Defining benchmarks for total and distal gastrectomy: global multicentre analysis 12
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022 11
Clinical predictors of postoperative complications in the context of enhanced recovery (ERAS) in patients with esophageal and gastric cancer 10
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer 10
Totale 4.921
Categoria #
all - tutte 21.543
article - articoli 20.766
book - libri 0
conference - conferenze 291
curatela - curatele 0
other - altro 377
patent - brevetti 0
selected - selezionate 0
volume - volumi 109
Totale 43.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020400 0 0 0 0 51 28 65 45 16 52 49 94
2020/2021511 83 63 20 81 58 47 4 5 21 10 66 53
2021/2022534 25 120 26 42 33 23 8 41 18 30 30 138
2022/20231.276 73 140 102 217 105 319 7 104 129 11 32 37
2023/2024848 17 58 57 97 65 168 40 47 16 75 151 57
2024/2025720 94 97 93 343 93 0 0 0 0 0 0 0
Totale 4.921